Update on ocular graft versus host disease

Current Opinion in Ophthalmology

Volumn 17, Issue 4, 2006, Pages 344-348

  Kim, Stella K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Allogeneic hematopoietic transplantation; Bone marrow transplantation; Keratoconjunctivitis sicca; Ocular graft versus host disease; Ocular surface disease

Indexed keywords

CYCLOSPORIN; RITUXIMAB; STEROID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; CICATRICIAL CONJUNCTIVITIS; CONJUNCTIVITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KERATOCONJUNCTIVITIS SICCA; LACRIMAL GLAND DISEASE; OCULAR GRAFT VERSUS HOST DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUVA; REVIEW; SCLERITIS;

DIAGNOSIS, DIFFERENTIAL; EYE DISEASES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME;

EID: 33747064094     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000233952.09595.d8     Document Type: Review

References (44)

1. Couriel D, Caldera H, Champlin R, et al. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004; 101:1936-1946.
2. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9:215-233.
3. Akpek G. Clinical grading in chronic graft-versus-host disease: is it time for change? Leuk Lymphoma 2002; 43:1211-1220.
4. Pavletic S, Vogelsang G. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series. Biol Blood Marrow Transplant 2005; 11:943-944.
5. Deeg HJ, Antin JH. The clinical spectrum of acute graft-versus-host disease. Semin Hematol 2006; 43:24-31.
6. Gilman AL, Serody J. Diagnosis and treatment of chronic graft-versus-host disease. Semin Hematol 2006; 43:70-80.
7. Kim SK. Ocular graft versus host disease. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. St Louis: Mosby; 2004. pp. 879-885.
8. Sheidow TG, Sexton B, Hooper PL, et al. Vitritis as the primary manifestation of graft-versus-host disease: a case report with vitreous cytopathology. Can J Ophthalmol 2004; 39:667-671.
9. Moon SJ, Mieler WF. Retinal complications of bone marrow and solid organ transplantation. Curr Opin Ophthalmol 2003; 14:433-442.
10. Kim RY, Anderlini P, Naderi AA, et al. Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. Am J Ophthalmol 2002; 133:843-845.
11. Fawzi AA, Cunningham ET Jr. Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001; 131:804-805.
12. Kaiserman I, Or R. Laser photocoagulation for central serous retinopathy associated with graft-versus-host disease. Ocul Immunol Inflamm 2005; 13:249-256.
13. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107:1343-1348.
14. Kim SK, Couriel D, Ghosh S, et al. Ocular graft vs. host disease experience from MD Anderson Cancer Center: newly described clinical spectrum and new approach to the management of Stage III and IV ocular GVHD. Biol Blood Marrow Transplant 2006; 12:S49.
15. Robinson MR, Lee SS, Rubin BI, et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33:1031-1035.
16. Jack MK, Jack GM, Sale GE, et al. Ocular manifestations of graft-v-host disease. Arch Ophthalmol 1983; 101:1080-1084.
17. Filipovich AH, Weisdorf G, Pavletic S, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945-956.
18. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for clinical trials in Chronic Graft-Versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12:375-396. Important summary of chronic GVHD treatment, including ocular GVHD.
19. Ferrara JL, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43:3-10.
20. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324:667-674.
21. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80:2964-2968.
22. Vogelsang GB. Acute and chronic graft-versus-host disease. Curr Opin Oncol 1993; 5:276-281.
23. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant 1990; 5:69-82.
24. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125:435-454.
25. De Wit D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150:361-366.
26. McCormick LL, Zhang Y, Tootell E, et al. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999; 163:5693-5699.
27. Anderson BE, McNiff JM, Jain D, et al. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005; 105:2227-2234.
28. Kim SK. Ocular graft vs host disease. Ocular Surface 2005; 3:177-179.
29. Rojas B, Cuhna R, Zafirakis P, et al. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 2005; 81:313-325.
30. Aronni S, Cortes M, Sacchetti M, et al. Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease. Eur J Ophthalmol 2006; 16:17-23.
31. Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981; 12:1022-1030.
32. Jabs DA, Hirst LW, Green WR, et al. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol 1983; 101:585-590.
33. West RH, Szer J, Pedersen JS. Ocular surface and lacrimal disturbances in chronic graft-versus-host disease: the role of conjunctival biopsy. Aust NZ J Ophthalmol 1991; 19:187-191.
34. Jack MK, Hicks JD. Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol 1981; 13:709-711.
35. Johnson DA, Jabs DA. The ocular manifestations of graft-versus-host disease. Int Ophthalmol Clin 1997; 37:119-133.
36. Ogawa Y, Yamazaki K, Kuwana M, et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42:111-119.
37. Ogawa Y, Kuwana M, Yamazaki K, et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003; 44:1888-1896.
38. Hassan AS, Clouthier SG, Ferrara JL, et al. Lacrimal gland involvement in graft-versus-host disease: a murine model. Invest Ophthalmol Vis Sci 2005; 46:2692-2697.
39. Ogawa Y, Kodama H, Kameyama K, et al. Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2005; 46:4519-4527.
40. Cutler C, Antin JH. Chronic graft-versus-host disease. Curr Opin Oncol 2006; 18:126-131.
41. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-vs.-host disease. Blood 2006 [Epub ahead of print].
42. Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107:3074-3080.
43. Antin JH. Donor leukocyte infusions and graft-versus-malignancy. J Clin Apher 2005; 20:113-116.
44. Hogan WJ, Deeg HJ. Stem cell transplantation: graft-mediated antileukemia effects. Methods Mol Med 2005; 109:421-444.